http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105801602-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D513-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-437 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D413-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-422 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D417-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-429 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5025 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4985 |
| filingDate | 2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-105801602-B |
| titleOfInvention | 5- tertiary Ding isoxazoles -3- bases -3- (4- substituted-phenyls) urea derivative and its preparation method and application |
| abstract | The invention belongs to chemical medicine, and in particular to 5 tertiary 3 base 3 (4 substituted-phenyl) urea derivatives of Ding isoxazoles and its preparation method and application.The present invention provides a kind of 5 tertiary 3 base 3 (4 substituted-phenyl) urea derivatives of Ding isoxazoles, its structure is as shown in formula I.Present invention also offers the preparation method and purposes of 5 tertiary 3 base 3 (4 substituted-phenyl) urea derivatives of Ding isoxazoles.The present invention obtains tertiary 3 base 3 (4 substituted-phenyl) urea derivative of Ding isoxazoles in above-mentioned 5 on the basis of a large amount of screenings, with the activity for suppressing human muscle creatine kinase cell Proliferation, new selection is provided to treat the development and application of acute myeloid leukaemia medicine. |
| priorityDate | 2014-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 232.